Get started
Author

Conor D. O’Donnell

Observed names: C. O'Donnell, Conor O'Donnell
ORCID: 0009-0009-6291-846X
Observed ORCID: 0009-0009-6291-846X
OpenAlex ID: A5121099280
Transplant Oncology in Evolution: Emerging Roles for Liver Transplant Beyond Hepatocellular Carcinoma
2026 · Ahmed A. Abdelhakeem, Conor D. O’Donnell, et al. · Cancers · 2
PDF
Outcomes of hyperthermic intraperitoneal chemotherapy (HIPEC) with cytoreduction in peritoneal metastatic pancreatic adenocarcinoma: Survival benefit and impact of germline genetic mutations.
2026 · Ahmed Abdelhakeem, Jakob Skyler Hamilton, et al. · Journal of Clinical Oncology
Dynamic disease trajectories, not treatment timing, as a driver of outcomes in intrahepatic cholangiocarcinoma: A machine learning analysis.
2026 · Nency Ganatra, Ahmed Abdelhakeem, et al. · Journal of Clinical Oncology
Real-world outcomes of FOLFOX with or without bevacizumab in small bowel and ampullary adenocarcinoma: A propensity-matched analysis.
2026 · Oluwatayo Adeoye, Yajur Arya, et al. · Journal of Clinical Oncology
First-line carboplatin-paclitaxel (CP) for metastatic anal squamous cell carcinoma (ASCC): An analysis of dosing schedules.
2026 · Jakob Skyler Hamilton, Oluwatayo Adeoye, et al. · Journal of Clinical Oncology
Circulating Biomarkers in Localized Anal Squamous Cell Carcinoma Across Treatment Timepoints: A Systematic Review
2026 · Oluwatayo Adeoye, Abdulsabur Sanni, et al. · Cancers
PDF
Impact of infusion timing (IT) on survival outcomes across gastrointestinal (GI) malignancies: A multicenter analysis of circadian rhythm (CR) effects on immune checkpoint inhibitor (ICI) activity.
2026 · Fares Jamal, Amal Youssef, et al. · Journal of Clinical Oncology
Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without Durvalumab
2026 · Naohiro Okano, Angelo Pirozzi, et al. · JCO oncology advances.
PDF
284P The role of body composition (BC) in patients (pts) with advanced biliary tract cancer (aBTC) receiving first-line (1L) chemoimmunotherapy (CIT)
2025 · N. Okano, A. Pirozzi, et al. · Annals of Oncology
Works count: 9
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type